Bile acid levels as a host factor affecting antiviral treatment response but not viral replication in hepatitis C patients
Rika Iwata(University Hospital Zurich), Avraham Geier(University Hospital Zurich), Beat Müllhaupt(University Hospital of Zurich), Bruno Stieger(University Hospital of Zurich), Athanasios Vergopoulos(University Hospital Zurich), Joshua E. Braun(University of Zurich), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Oliver Goetze(University Hospital Zurich), Karim Sabrane(University Hospital Zurich)
Cited by 0
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309